Previously, scientists have been able to show that a protein molecule known as PKM zeta is required to store memories. In the case of chronic pain, there is a malfunctioning in the neural process that stores those memories, which prevents the brain from adapting the subsequent behavioural response which would ordinarily allow it to cope with the pain.
The connections between neurons through synaptic pathways in the central nervous system are somehow flawed, causing an individual to re-experience pain as the mental record of that pain persists.
This new research has detected the cause for this malfunction and in doing so, has identified a novel target for the treatment of neuropathic pain. By inhibiting PKM zeta in a part of the brain involved in the perception of pain in a mouse model, the international team of scientists have been able to eliminate the painful memory responsible for chronic pain.
Professor Graham Collingridge, from the University of Bristol’s MRC Centre for Synaptic Plasticity, the School of Physiology and Pharmacology, and part of the Bristol Neuroscience network, said: “If this translates to humans, it may be possible one day to treat some forms of chronic pain by inhibiting PKM zeta or other molecules involved in the storage of the painful memory. The challenge will be to target the drug so that it inhibits painful memories but not other forms of memory. “
By studying how brain connections operate in a part of the cortex involved in pain sensation in mice, the team found that the molecule PKM zeta actually serves to maintain pain-induced persistent changes in the brain, thereby prolonging the sensation of chronic pain.
The team combined biochemistry, electrophysiology and behaviour to study the role of PKM zeta in the anterior cingulate cortex, a brain region known to be activated in humans during painful states. The identification of a molecular basis for chronic pain provides a framework for the development of more effective therapies in the future.
Paper: Alleviating Neuropathic Pain Hypersensitivity by Inhibiting PKMzeta in the Anterior Cingulate Cortex, is published online by the journal Science, at the Science Express web site on Thursday 2 December 2010.Science and Science Express are published by the AAAS, the science society, the world’s largest general scientific organisation.
Please contact Aliya Mughal for further information.
Bristol Neuroscience: Neuroscience is one of the key areas of research at the University of Bristol. The city of Bristol has one of the largest concentrations of researchers engaged in neuroscience in the UK, many of whom are internationally recognised. In 2003 Bristol Neuroscience (BN) was established to enable all neuroscientists working in Bristol – both within the University and its partner hospitals across the city – to make full use of all available resources and expertise. BN runs numerous activities to encourage the dissemination of ideas, to create opportunities for interdisciplinary research, and to facilitate the pursuit of neuroscience to the highest possible standard. For further information on BN see www.bris.ac.uk/neuroscience or contact Dr Anne Cooke, email@example.com.